Epsilon M&A Deal Report - Bluegnome
Transaction Multiples for the Valuation of Private Companies
Illumina / Bluegnome
No EMAT :
67500
Announced Date :
19/09/2012
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Illumina
Target :
Bluegnome
Country :
England
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
Business Description :
Founded in 2001 by Nick Haan and Graham Snudden as a spin-out from the Cambridge University, BlueGnome is a biotechnology company that provides genetic diagnostic solutions for the screening of...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
|
|
|
|
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
| Date | Acquirer | Target | Country | Multiples | See details |
| 16/01/2014 | Eurofins Scientific | IDmyk (now Eurofins ID Myk) | France | ** | 67214 |
| 30/04/2014 | Private Group led by Salvepar | S2A Group (now Asten Group) | France | * | 66994 |
Source: Epsilon Research / EMAT
